Status:

RECRUITING

OTC Hearing Aid and MCI

Lead Sponsor:

Northwestern University

Conditions:

Hearing Loss

Mild Cognitive Impairment

Eligibility:

All Genders

60-90 years

Phase:

NA

Brief Summary

The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias...

Detailed Description

This is a single blind cross-over study comparing OTC Hearing Aids to communication strategies information/counseling and their impact on communication between a person who has hearing loss and MCI an...

Eligibility Criteria

Inclusion

  • Over 60 years of age
  • Mild dementia or mild cognitive impairment. Diagnosis will be made at participating memory evaluation centers (see recruitment).
  • Mild to moderate bilateral hearing loss and no current hearing aid use.
  • A communication partner who is able and willing to participate in the study.
  • No vision impairment that would interfere with the ability to complete study tasks (i.e., legally blind, severe cataracts, or macular degeneration)
  • Able to provide own consent as evaluated by the Consent Assessment

Exclusion

  • Clinically significant unstable or progressive medical conditions, or conditions which, in the opinion of the investigator(s) places the participant at unacceptable risk if he or she were to participate in the study.
  • History of unresolved communication difficulties following another neurological problem (i.e., stroke or brain tumor), neurodevelopmental disorder (i.e., Down's syndrome), or head/neck cancer
  • Positive history of major psychiatric disorder (i.e., schizophrenia, significant untreated depression)
  • Co-enrolled in other intervention studies targeting hearing, language, or communication strategies.
  • History or current fluctuating hearing loss

Key Trial Info

Start Date :

July 23 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06112860

Start Date

July 23 2024

End Date

December 31 2026

Last Update

September 19 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Northwestern University HA Lab

Evanston, Illinois, United States, 60201

2

La Crosse Mayo Clinic

La Crosse, Wisconsin, United States, 54601

3

UW Madison

Madison, Wisconsin, United States, 53706